BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 31911409)

  • 1. Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes.
    Pierson SK; Lim MS; Srkalovic G; Brandstadter JD; Sarmiento Bustamante M; Shyamsundar S; Mango N; Lavery C; Austin B; Alapat D; Lechowicz MJ; Bagg A; Li H; Casper C; van Rhee F; Fajgenbaum DC
    Blood Adv; 2023 Nov; 7(21):6652-6664. PubMed ID: 37656441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating plasmablastic cells in a patient with HHV-8-associated multicentric Castleman disease and Kaposi sarcoma.
    Tashakori M; Beckman AK
    Blood; 2023 Dec; 142(24):2124. PubMed ID: 38095919
    [No Abstract]   [Full Text] [Related]  

  • 3. Idiopathic multicentric Castleman disease and its rare association with peripheral neuropathy and stroke.
    Hatta BWM; Syafiqah S; Rasheed M; Vegagonzalez M; Leong WB; Bashir A
    Clin Med (Lond); 2023 Nov; 23(Suppl 6):1. PubMed ID: 38182226
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful Renal Transplant in Castleman Disease - First Case Report from India.
    Maitra S; Maitra D; Gowrishankar S
    Indian J Nephrol; 2023; 33(4):296-299. PubMed ID: 37781546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Herpesvirus 8-Positive Multicentric Castleman Disease in an Immunocompetent Patient: A Diagnostic Challenge.
    Magalhães ARG; Santos MB; Almeida PH; Carvalho AMF; Exposito BT
    Cureus; 2024 Mar; 16(3):e56534. PubMed ID: 38646242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory idiopathic multicentric Castleman disease responsive to sirolimus therapy.
    Bayram E; Pehlivan UA; Fajgenbaum DC; Paydas S
    Am J Hematol; 2023 Feb; 98(2):361-364. PubMed ID: 36401154
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal pelvic involvement in multicentric Castleman disease.
    Ueda Y; Nagata R; Setoguchi K
    Rheumatol Adv Pract; 2024; 8(1):rkad108. PubMed ID: 38115887
    [No Abstract]   [Full Text] [Related]  

  • 8. Case report: Importance of early and continuous tocilizumab therapy in nephrotic syndrome associated with idiopathic multicentric Castleman disease: A case series.
    Kojima D; Yamaguchi S; Hashiguchi A; Hayashi K; Uchiyama K; Yoshimoto N; Adachi K; Nakayama T; Nishioka K; Tajima T; Morimoto K; Yoshino J; Yoshida T; Monkawa T; Kanda T; Itoh H
    Front Med (Lausanne); 2022; 9():1037032. PubMed ID: 36698794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five biopsies, one diagnosis: challenges in idiopathic multicentric Castleman disease.
    Semenchuk J; Merchant A; Sakhdari A; Kukreti V
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33229481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal complications of Castleman's disease: report of two cases and analysis of 75 cases.
    Yuan XG; Hu W; Chen FF; Huang BF; Zhao XY
    Clin Exp Nephrol; 2011 Dec; 15(6):921-6. PubMed ID: 21822592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic multicentric Castleman disease with Sjögren's syndrome and secondary membranous nephropathy: a case report and review of the literature.
    Pan Y; Cui Z; Wang S; Zheng D; Deng Z; Tian X; Guo H; Bao W; Zhou S; Wang Y
    BMC Nephrol; 2020 Dec; 21(1):528. PubMed ID: 33276741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HHV-8-negative multicentric Castleman disease presenting as a crescentic immune complexes membranoproliferative glomerulonephritis.
    Nunes MB; Rotman S; Duss FR; Halfon M
    BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31911409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successfully treated multicentric Castleman's disease with renal thrombotic microangiopathy using rituximab and corticosteroid.
    Lee JP; Kim DK; Oh DY; Paik JH; Moon KC; Kim S; Kim YS
    Clin Nephrol; 2011 Feb; 75(2):165-70. PubMed ID: 21255547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful use of rituximab in glomerular basement membrane nephritis associated with HIV interstitial nephritis secondary to Castleman disease
.
    Calabro N; Henriksen K; Lim SH; Kerns E
    Clin Nephrol; 2018 Jun; 89(6):469-473. PubMed ID: 29424337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief communication: rituximab in HIV-associated multicentric Castleman disease.
    Bower M; Powles T; Williams S; Davis TN; Atkins M; Montoto S; Orkin C; Webb A; Fisher M; Nelson M; Gazzard B; Stebbing J; Kelleher P
    Ann Intern Med; 2007 Dec; 147(12):836-9. PubMed ID: 18087054
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.